Cuiyun Li

机构：Jilin University, First Hospital of Jilin University · ORCID：0000-0002-6306-2394

发表论文 131 篇 · 总被引 1916 次 · h-index 21

代表论文

• Safety, tolerability, pharmacokinetics, and antiviral activity of the novel core protein allosteric modulator ZM-H1505R (Canocapavir) in chronic hepatitis B patients: a randomized multiple-dose escalation trial (2023 · BMC Medicine · 被引 21)
• Safety, pharmacokinetics and pharmacodynamics of a novel γ-aminobutyric acid (GABA) receptor potentiator, HSK3486, in Chinese patients with hepatic impairment (2022 · Annals of Medicine · 被引 17)
• A shark-derived broadly neutralizing nanobody targeting a highly conserved epitope on the S2 domain of sarbecoviruses (2025 · Journal of Nanobiotechnology · 被引 12)
• Distinguishing functional and structural MRI abnormalities between bipolar and unipolar depression (2023 · Frontiers in Psychiatry · 被引 10)
• Comparison of Pharmacokinetic Similarity, Immunogenicity, and Safety of Ustekinumab and BAT2206 in Healthy Chinese Male Subjects in a Double-Blind, Randomized, Single-Dose, Parallel-Group Phase I Trial (2022 · BioDrugs · 被引 9)
• Single‐Dose Tolerability and Pharmacokinetics of Onradivir in Chinese Patients with Hepatic Impairment and Healthy Matched Controls (2024 · The Journal of Clinical Pharmacology · 被引 8)